MADISON HEIGHTS, Mich.,
Sept. 9, 2016 /PRNewswire/
-- InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading
national provider of infusion pumps and related services for the
healthcare industry in the United
States, today announced the election of Mr. Scott A. Shuda to serve as a new member of
InfuSystem Holdings Board of Directors, effective September 7, 2016.
Mr. Shuda is a managing director and co-founder of Meridian OHC
Partners LP and BlueLine Partners, LLC, investment firms that focus
on publicly listed technology and healthcare companies. Mr. Shuda
has served as a director of Iridex Corporation, a global leader in
ophthalmic laser systems, since 2012 and is currently chairman of
the Iridex Compensation Committee and a member of the Nominating
and Governance Committee. From 2010 to 2011 Mr. Shuda served as a
director and audit committee member of MGC Diagnostics Corporation
(formerly Angeion Corporation), a global respiratory diagnostics
company. Prior to co-founding BlueLine Partners in April 2004, Mr. Shuda was general counsel to
Vicinity Corporation, an internet search company that went public
in 2000 and was acquired by Microsoft in 2002. Prior to his
employment with Vicinity, Mr. Shuda practiced law in California and New
York, most recently in the Silicon Valley office of Latham
& Watkins LLP. Mr. Shuda holds both J.D. and M.B.A. degrees
from Georgetown University.
Eric K. Steen, chief executive
officer of InfuSystem, said, "We are pleased that Scott will join
InfuSystem's Board of Directors. Scott has built a distinguished
career as an investment manager along with 20 years of professional
services experience in law and technology. His experience working
with healthcare companies and understanding of the capital markets
will add an additional layer of financial analytics and his
perspective as our largest stockholder will be an asset to the
Board."
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion
pumps and related services to hospitals, oncology practices and
other alternate site healthcare providers. Headquartered in
Madison Heights, Michigan, the
Company delivers local, field-based customer support and also
operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company's stock is
traded on the NYSE MKT under the symbol INFU.
Forward-Looking Statements
Certain statements contained in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the "Securities Act") and
Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "should," "plan," "expect,"
"strategy," "future," "likely," variations of such words, and other
similar expressions, as they relate to the Company, are intended to
identify forward-looking statements. However, the absence of
these words or similar expressions does not mean that a statement
is not forward-looking. In connection with the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995,
the Company is identifying certain factors that could cause actual
results to differ, perhaps materially, from those indicated by
these forward-looking statements. Those factors, risks and
uncertainties include, but are not limited to, potential changes in
overall healthcare reimbursement, including CMS competitive
bidding, sequestration, concentration of customers, increased focus
on early detection of cancer, competitive treatments, dependency on
Medicare Supplier Number, availability of chemotherapy drugs,
global financial conditions, changes and enforcement of state and
federal laws, natural forces, competition, dependency on suppliers,
risks in acquisitions & joint ventures, U.S. Healthcare Reform,
relationships with healthcare professionals and organizations,
technological changes related to infusion therapy, dependency on
websites and intellectual property, the ability of the Company to
successfully integrate acquired businesses, dependency on key
personnel, dependency on banking relations and covenants, and other
risks associated with our common stock, as well as any litigation
to which the Company may be involved in from time to time; and
other risk factors as discussed in the Company's annual report on
Form 10-K for the year ended December 31,
2015 and in other filings made by the Company from time to
time with the Securities and Exchange Commission, including our
Form 10-Q for the second quarter of 2016. Our annual report
on Form 10-K is available on the SEC's EDGAR website at
www.sec.gov, and a copy may also be obtained by contacting the
Company. All forward-looking statements made in this press release
speak only as of the date hereof. We do not intend, and do
not undertake any obligation, to update any forward-looking
statements to reflect future events or circumstances after the date
of such statements.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
CONTACT:
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
Lytham Partners,
LLC
|
|
602-889-9700
|
Logo -
http://photos.prnewswire.com/prnh/20160415/356049LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/infusystem-holdings-inc-announces-the-election-of-scott-a-shuda-to-the-board-of-directors-300325339.html
SOURCE InfuSystem Holdings, Inc.